Abstract:BACKGROUND:Human embryonic stem cells have prospective uses in regenerative medicine and drug screening. Every human embryonic stem cell line has its own genetic background, which determines its specific ability for differentiation as well as susceptibility to drugs. It is necessary to compile many human embryonic stem cell lines with various backgrounds for future clinical use, especially in China due to its large population. This study contributes to isolating new Chinese human embryonic stem cell lines with clarified directly differentiation ability.METHODS:Donated embryos that exceeded clinical use in our in vitro fertilization-embryo transfer (IVF-ET) center were collected to establish human embryonic stem cells lines with informed consent. The classic growth factors of basic fibroblast growth factor (bFGF) and recombinant human leukaemia inhibitory factor (hLIF) for culturing embryonic stem cells were used to capture the stem cells from the plated embryos. Mechanical and enzymetic methods were used to propagate the newly established human embryonic stem cells line. The new cell line was checked for pluripotent characteristics with detecting the expression of stemness genes and observing spontaneous differentiation both in vitro and in vivo. Finally similar step-wise protocols from definitive endoderm to target specific cells were used to check the cell line's ability to directly differentiate into pancreatic and hepatic cells.RESULTS:We generated a new Chinese human embryonic stem cells line, CH1. This cell line showed the same characteristics as other reported Chinese human embryonic stem cells lines: normal morphology, karyotype and pluripotency in vitro and in vivo. The CH1 cells could be directly differentiated towards pancreatic and hepatic cells with equal efficiency compared to the H1 cell line.CONCLUSIONS:This newly established Chinese cell line, CH1, which is pluripotent and has high potential to differentiate into pancreatic and hepatic cells, will provide a useful tool for embryo development research, along with clinical treatments for diabetes and some hepatic diseases.

Ethical Management of Study on Human Embryonic Stem Cells Isolation

[Progress in the Derivation, Culture of Human Embryonic Stem Cells].

Ethical issues and countermeasures of stem cell research in China

Derivation, Characterization and Differentiation of a New Human Embryonic Stem Cell Line from a Chinese Hatched Blastocyst Assisted by a Non-Contact Laser System

Ethical and Policy Considerations for Human Embryo and Stem Cell Research in China

Requirements for human embryonic stem cells

Ethical Issues, Ethical Norms and Ethical Empirical Researches on Stem Cell Research and Application

[Current State of Establishing and Maintaining Human Embryonic Stem Cell Lines and Key Problems in These Studies].

Ethics and management of surplus embryos for research

Thoughts on advancing the stem cell clinical research

Discuss of Ethics Problems of Stem Cell Regeneration Biology Research and Clinical Application

Accreditation of Biosafe Clinical-Grade Human Embryonic Stem Cells According to Chinese Regulations

Investigation and Discussion on the Ethical Issues of Therapeutic Cloning and Human Embryo Administrative

Establishment of a clinical grade human umbilical cord mesenchymal stem cells bank

Ethics Review of the Research of Human Embryonic Stem Cells

The ISSCR Guidelines for Human Embryonic Stem Cell Research

Ethical Controversy in Embryonic Stem Cell Research and Discussions on Public Policies

Derivation and Characterization of Chinese Human Embryonic Stem Cell Line with High Potential to Differentiate into Pancreatic and Hepatic Cells

Technical Specifications for Ethics Review of Human Stem Cell Research

Discussion on the Transfer of Human Gamete and Embryos

Strategy exploration on strengthening the quality control of stem cell clinical research